Free Trial

TBH Global Asset Management LLC Purchases 5,451 Shares of The Cigna Group (NYSE:CI)

→ Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad)
The Cigna Group logo with Medical background

TBH Global Asset Management LLC raised its stake in shares of The Cigna Group (NYSE:CI - Free Report) by 65.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,747 shares of the health services provider's stock after acquiring an additional 5,451 shares during the quarter. The Cigna Group makes up 0.8% of TBH Global Asset Management LLC's portfolio, making the stock its 28th biggest position. TBH Global Asset Management LLC's holdings in The Cigna Group were worth $4,117,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Relyea Zuckerberg Hanson LLC lifted its position in The Cigna Group by 3.2% in the 4th quarter. Relyea Zuckerberg Hanson LLC now owns 1,113 shares of the health services provider's stock valued at $333,000 after purchasing an additional 35 shares during the last quarter. Legacy Financial Advisors Inc. lifted its position in The Cigna Group by 3.1% in the 4th quarter. Legacy Financial Advisors Inc. now owns 1,250 shares of the health services provider's stock valued at $374,000 after purchasing an additional 37 shares during the last quarter. Sequoia Financial Advisors LLC lifted its position in The Cigna Group by 1.4% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 2,822 shares of the health services provider's stock valued at $807,000 after purchasing an additional 39 shares during the last quarter. Breakwater Capital Group lifted its position in The Cigna Group by 3.5% in the 4th quarter. Breakwater Capital Group now owns 1,144 shares of the health services provider's stock valued at $349,000 after purchasing an additional 39 shares during the last quarter. Finally, Detalus Advisors LLC lifted its position in The Cigna Group by 6.0% in the 4th quarter. Detalus Advisors LLC now owns 742 shares of the health services provider's stock valued at $222,000 after purchasing an additional 42 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.


Wall Street Analyst Weigh In

A number of research firms have commented on CI. Wells Fargo & Company boosted their price target on shares of The Cigna Group from $334.00 to $348.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 6th. Barclays started coverage on shares of The Cigna Group in a report on Wednesday, March 6th. They issued an "overweight" rating and a $393.00 target price on the stock. Cantor Fitzgerald boosted their target price on shares of The Cigna Group from $384.00 to $400.00 and gave the stock an "overweight" rating in a report on Friday, May 3rd. Royal Bank of Canada upgraded shares of The Cigna Group from a "sector perform" rating to an "outperform" rating and boosted their target price for the stock from $327.00 to $354.00 in a report on Monday, February 5th. Finally, Mizuho boosted their target price on shares of The Cigna Group from $360.00 to $370.00 and gave the stock a "buy" rating in a report on Monday, February 5th. Two equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $366.14.

Read Our Latest Analysis on CI

The Cigna Group Stock Performance

Shares of NYSE CI traded down $5.30 during trading hours on Friday, hitting $332.53. 1,311,592 shares of the stock were exchanged, compared to its average volume of 1,587,786. The company has a debt-to-equity ratio of 0.75, a current ratio of 0.71 and a quick ratio of 0.71. The company's 50 day moving average is $351.38 and its 200 day moving average is $322.97. The firm has a market capitalization of $94.46 billion, a P/E ratio of 27.74, a P/E/G ratio of 1.03 and a beta of 0.57. The Cigna Group has a one year low of $240.50 and a one year high of $365.71.

The Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, May 2nd. The health services provider reported $6.47 EPS for the quarter, beating the consensus estimate of $6.17 by $0.30. The firm had revenue of $57.25 billion during the quarter, compared to analysts' expectations of $56.59 billion. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The business's quarterly revenue was up 23.2% compared to the same quarter last year. During the same period in the prior year, the company earned $5.41 EPS. On average, research analysts expect that The Cigna Group will post 28.47 EPS for the current year.

The Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 20th. Stockholders of record on Tuesday, June 4th will be paid a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.68%. The ex-dividend date is Tuesday, June 4th. The Cigna Group's dividend payout ratio is 45.98%.

Insider Activity

In other news, CEO David Cordani sold 2,412 shares of the company's stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $345.73, for a total value of $833,900.76. Following the sale, the chief executive officer now owns 340,438 shares of the company's stock, valued at approximately $117,699,629.74. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other The Cigna Group news, CEO David Cordani sold 2,412 shares of the stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $345.73, for a total transaction of $833,900.76. Following the sale, the chief executive officer now owns 340,438 shares of the company's stock, valued at approximately $117,699,629.74. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Noelle K. Eder sold 10,700 shares of the stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $348.47, for a total transaction of $3,728,629.00. Following the sale, the insider now directly owns 15,824 shares in the company, valued at approximately $5,514,189.28. The disclosure for this sale can be found here. In the last 90 days, insiders sold 72,366 shares of company stock worth $25,440,835. 0.60% of the stock is currently owned by corporate insiders.

About The Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

→ Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad)

Should you invest $1,000 in The Cigna Group right now?

Before you consider The Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.

While The Cigna Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Will FOMC Push Stocks Higher? Here’s What to Expect
Unlock Growth: Understanding Dividend Yield
Palantir Stock Excluded from S&P 500: Still a Buy?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines